Enliven Therapeutics Inc (ELVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -89,024 | -71,584 | -37,662 | -51,384 | -41,360 |
| Depreciation Amortization | 741 | -4,306 | 215 | 254 | 219 |
| Accounts payable and accrued liabilities | 810 | -2,250 | 411 | 389 | 313 |
| Other Working Capital | -4,541 | 1,401 | 438 | 514 | 1,512 |
| Other Operating Activity | 18,822 | 15,470 | 4,521 | 3,456 | 1,918 |
| Operating Cash Flow | $-73,192 | $-61,269 | $-32,077 | $-46,771 | $-37,398 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,826 | -148,263 | 0 | -1,620 | -16,703 |
| PPE Investments | -44 | -149 | -612 | -12 | -18 |
| Other Investing Activity | 873 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-35,997 | $-148,412 | $-612 | $-1,632 | $-16,721 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 47,000 | N/A |
| Common Stock Issued | 93,977 | 399 | 591 | 860 | 81,449 |
| Other Financing Activity | 39,188 | 233,887 | -2,390 | 1,241 | 15,432 |
| Financing Cash Flow | $133,165 | $234,286 | $-1,799 | $49,101 | $96,881 |
| Beginning Cash Position | 100,195 | 75,590 | 110,078 | 47,786 | 5,024 |
| End Cash Position | 124,171 | 100,195 | 75,590 | 48,484 | 47,786 |
| Net Cash Flow | $23,976 | $24,605 | $-34,488 | $698 | $42,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -73,192 | -61,269 | -32,077 | -46,771 | -37,398 |
| Capital Expenditure | -44 | -149 | -612 | -12 | -18 |
| Free Cash Flow | -73,236 | -61,418 | -32,689 | -46,783 | -37,416 |